This deteriorated adipose tissue function contributes to impaired hepatic insulin sensitivity (as demonstrated by decreased IRS1 expression, Figure 4J) and pronounced hepatic steatosis (as evident by abundant lipid droplets and higher liver weight) (Figures 4D, E). This evidence concerns the gene INS and fatty liver disease.